Indian Pharma sector growth to moderate at 8-10% CAGR over FY’2018-21: ICRA
High base for domestic business impacted Q3FY2019 growth, and moderation in pricing pressure, new launches and currency…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Wockhardt receives US FDA approval for cancer drug
This is the third US FDA approval for an oncology product for Wockhardt during the past three months
US FDA approves ViiV Healthcare’s Dovato
Dovato strengthens ViiV Healthcare’s industry-leading portfolio of innovative treatment approaches for people living with HIV
Lupin launches Fluoxetine tabs
The drug is indicated in the treatment of major depressive disorder, obsessive compulsive disorder, bulimia nervosa
Global eye care giant Alcon lists at Swiss Exchange
The listing is expected to be one of Europe’s largest in the coming year and will be split across SIX and the NYSE
Intas Pharma launches Trastuzumab biosimilar
Eleftha will bring down the treatment cost by 65 per cent
CCRH to organise international convention on World Homoeopathy Day
The convention will deliberate on linking education and clinical practice with research
IndiaRF invests $144 million in Panacea Biotec
Investment to be used for one-time settlement with existing lenders, working capital and growth requirements
Bayer Animal Health launches Seresto in India
Seresto is designed to deal with the vagaries of climate change and the resultant rise in temperatures across the globe that makes…
Vanta Bioscience signs Rs 29 crores deal with Emcure Pharmaceuticals
To provide services through its step-down subsidiary ‘Vayam Research Solutions’
Zydus Cadila gets US FDA nod to market generic anti-epileptic tablets
The drug will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad
Evonik Catalysts expands production of activated metal catalysts in India
The new state-of-the-art production facility allows Evonik to fully utilise its capacities in Dombivli while establishing…
Syngene International, BIRAC set up CAPS
The collaboration is part of National Biopharma Mission
Syngene International announced the opening of its Centre for Advanced…
Sun Pharma launches ready-to-infuse INFUGEM in the US
INFUGEM (gemcitabine in sodium chloride injection) is the first and only chemotherapy product in a premixed, ready-to-infuse…
Purdue’s Sackler family fights ‘inflammatory’ Massachusetts opioid case
The case is among roughly 2,000 lawsuits filed mostly by state and local governments seeking to hold Purdue and other…
Japan’s Takeda invites Brazilian pharmaceutical firms to bid for Latam business: Sources
Takeda expects to fetch more than $1 billion for the Latin American operations. In Brazil, Takeda owns popular over the counter…
Servier joins Access Accelerated to fight against non-communicable diseases
Now consisting of 26 pharmaceutical companies, Access Accelerated unites industry action and applies member companies' global…
Lupin’s Pithampur Unit-3 (Indore) receives EIR from USFDA
Lupin’s Pithampur Unit-3 is involved in the manufacture of Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs) and Topical…
Exports in March to reach $32.38 billion: Suresh Prabhu
Exports will cross the $331-billion mark in the year 2018-19, Commerce and Industry Minister said
Aurobindo Pharma, Lupin recall drugs in US market
The USFDA has classified the action for Aurobindo Pharma as a Class II recall, and for Lupin, the health regulator classified the…